LINK ALTERNATIF MBL77 Options
Not all patients with CLL require therapy. In spite of all modern advancements, the iwCLL continue to suggests watchful observation for patients with asymptomatic condition.86 This suggestion relies on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).